PODD.US stock price

Insulet

160.67 USD

+2.94 (+1.86%)

1MN

PODD.US Key Statistics

Open price

157.73

High today

161.15

Low today

157.79

52 Week high

353.56

52 Week low

138.28

Trading hours

-12:00

-11:00

-10:00

-09:00

-08:00

-07:00

-06:00

-05:00

-04:00

-03:00

-02:00

-01:00

UTC 00:00

+01:00

+02:00

+03:00

+03:30

+04:00

+04:30

+05:00

+05:30

+05:45

+06:00

+07:00

+08:00

+09:00

+09:30

+10:00

+11:00

+12:00

+12:45

+13:00

+14:00

UTC 00:00

Symbol trading specification

Trade Insulet

About PODD.US

The Insulet (PODD.US) stock price draws interest from investors focused on healthcare technology and chronic disease management solutions.

What is Insulet?

Insulet Corporation develops and markets tubeless insulin pumps, serving individuals with diabetes. The company has positioned itself at the intersection of biotechnology and wearable tech, addressing a growing demand for user-friendly diabetes management tools. Those looking to understand how to trade PODD.US can start by opening a demo account on the SimpleFX platform. It allows new users to simulate trade in equities listed on the S&P500 without financial commitment. There is no minimum deposit required on SimpleFX, making it accessible for newcomers. Once switched to a live account, traders can utilize leverage options.

Current PODD.US stock price

The PODD.US stock price highlights the valuation of Insulet Corporation, a medical device company specializing in insulin delivery systems. The PODD.US live price can be followed on the SimpleFX website or Webtrader platform.

How does Insulet work?

Insulet generates revenue primarily through the sale of insulin delivery devices and related supplies. The company operates on a recurring revenue model, as users continuously purchase disposable pods for daily treatment. For those exploring how to invest in PODD.US, SimpleFX provides access to this and many other global equities, enabling broader portfolio diversification. The Insulet stock price movements may depend on product adoption rates, clinical trial results, healthcare policy shifts, and competition within the medtech space. Partnerships, regulatory approvals, and technological advancements in diabetes care can significantly affect investor sentiment.

PODD.US chart

The PODD.US chart highlights Insulet Corporation’s price activity, complemented by indicators enabling structured technical studies. The Insulet chart is equally accessible in a demo account that mirrors the full version’s analytical functionality.

Insulet stock price history

Since its IPO in 2007, Insulet’s stock price has reflected its transition from a niche player to a recognized name in diabetes care. Major milestones, such as new product launches and FDA approvals, have contributed to growth spurts in valuation.

PODD.US market cap

The Insulet market cap serves as an indicator of the company’s role in the U.S. healthcare technology sector. While it doesn’t rank among the top 10 in the broader healthcare industry, the PODD.US market cap holds a respectable position within the top 50 medtech firms.